Effect of baseline levels on response of high-density lipoprotein cholesterol to hypolipidemic treatment

Genovefa D Kolovou; Deliana C Daskalova; Ilias I Petropoulos; Katherine K Anagnostopoulou; Helen I Bilianou; Nektarios D Pilatis; Antonis N Pavlidis; Dennis V Cokkinos

doi:10.1016/j.amjcard.2003.08.022

Effect of baseline levels on response of high-density lipoprotein cholesterol to hypolipidemic treatment

Am J Cardiol. 2003 Dec 1;92(11):1339-42. doi: 10.1016/j.amjcard.2003.08.022.

Authors

Genovefa D Kolovou¹, Deliana C Daskalova, Ilias I Petropoulos, Katherine K Anagnostopoulou, Helen I Bilianou, Nektarios D Pilatis, Antonis N Pavlidis, Dennis V Cokkinos

Affiliation

¹ First Cardiology Department, Onassis Cardiac Surgery Center, Athens, Greece. [email protected]

PMID: 14636917
DOI: 10.1016/j.amjcard.2003.08.022

Abstract

The response of high-density lipoprotein cholesterol to hypolipidemic monotherapy with diet, statins, fibrates, or nicotinic acid was investigated prospectively in 801 patients with dyslipidemia. We hypothesized that the behavior of high-density lipoprotein cholesterol after treatment would depend on its baseline levels and the therapy used.

MeSH terms

Cholesterol, HDL / blood
Cholesterol, HDL / drug effects*
Female
Humans
Hyperlipidemias / diet therapy*
Hyperlipidemias / drug therapy*
Hypolipidemic Agents / therapeutic use
Linear Models
Male
Middle Aged
Niacin / therapeutic use
Prospective Studies
Statistics, Nonparametric
Treatment Outcome

Substances

Cholesterol, HDL
Hypolipidemic Agents
Niacin